This HTML5 document contains 59 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
n11http://dx.doi.org/10.1161/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q73492524
rdf:type
wikibase:Item
schema:description
наукова стаття, опублікована в лютому 2000 scientific article published on 01 February 2000 wetenschappelijk artikel im Februar 2000 veröffentlichter wissenschaftlicher Artikel artikull shkencor i botuar më 01 shkurt 2000 wüsseschaftlicher Artikel, wo im Hornig 2000 veröffentlicht worden isch artículu científicu espublizáu en febreru de 2000
p:P577
wds:Q73492524-FF5B4886-850E-4677-BDE2-F9198C3DC685
wdt:P577
2000-02-01T00:00:00Z
p:P407
wds:Q73492524-744D2CD8-292B-4AED-9F93-5A2E2195A953
wdt:P407
wd:Q1860
p:P2093
wds:Q73492524-405D95CC-2D9A-43FA-AB43-4CA052B8F998 wds:Q73492524-2A8EED86-1C3F-4323-B0A8-72B31ABA423B wds:Q73492524-D8136DED-5D55-408F-AE54-2AC7C201128F wds:Q73492524-F12D7FAF-2CA3-471E-B426-2573B9FD9E86 wds:Q73492524-C4BE033F-F4E8-4AF7-8E1B-A8E3D1FFEA71 wds:Q73492524-BE3EC9DB-2586-4345-8D35-837EEA237D39 wds:Q73492524-9E17AAA1-2400-4C2A-9ADB-61A108120589 wds:Q73492524-7B955ED4-E7BA-487C-A572-5871933553D3 wds:Q73492524-7F8B878B-70AD-4FA1-95E4-EB852C3169C4
wdt:P2093
Le Jemtel TH Sonnenblick EH Cukon S Lisker J Jorde UP Hammer A Suryadevara V Ennezat PV Infeld J
rdfs:label
Maximally recommended doses of angiotensin-converting enzyme (ACE) inhibitors do not completely prevent ACE-mediated formation of angiotensin II in chronic heart failure Maximally recommended doses of angiotensin-converting enzyme Maximally recommended doses of angiotensin-converting enzyme (ACE) inhibitors do not completely prevent ACE-mediated formation of angiotensin II in chronic heart failure
skos:prefLabel
Maximally recommended doses of angiotensin-converting enzyme (ACE) inhibitors do not completely prevent ACE-mediated formation of angiotensin II in chronic heart failure Maximally recommended doses of angiotensin-converting enzyme (ACE) inhibitors do not completely prevent ACE-mediated formation of angiotensin II in chronic heart failure Maximally recommended doses of angiotensin-converting enzyme
schema:name
Maximally recommended doses of angiotensin-converting enzyme (ACE) inhibitors do not completely prevent ACE-mediated formation of angiotensin II in chronic heart failure Maximally recommended doses of angiotensin-converting enzyme (ACE) inhibitors do not completely prevent ACE-mediated formation of angiotensin II in chronic heart failure Maximally recommended doses of angiotensin-converting enzyme
p:P1476
wds:Q73492524-5C8C426E-276D-4787-8C0F-585DA6A2784F
wdt:P1476
Maximally recommended doses of angiotensin-converting enzyme (ACE) inhibitors do not completely prevent ACE-mediated formation of angiotensin II in chronic heart failure
p:P304
wds:Q73492524-6C39183E-9A03-4708-B869-268712BE729B
wdt:P304
844-846
p:P31
wds:Q73492524-C57154CC-BBD2-44B1-ADAE-160B104A4DCE
wdt:P31
wd:Q13442814
p:P921
wds:Q73492524-BCAF7CF2-ED35-4AC0-A0C0-8D6811F74CF0
wdt:P921
wd:Q11829287
p:P698
wds:Q73492524-39218A14-FA70-4048-9307-F43E0E9AFF29
wdtn:P698
n12:10694521
wdt:P698
10694521
p:P1433
wds:Q73492524-08A0DDF3-C038-4CE9-93B6-14CBB06845A6
wdt:P1433
wd:Q578091
p:P433
wds:Q73492524-45F0565C-008B-4956-9186-A4CFC575BD6A
p:P478
wds:Q73492524-225D0082-0BF9-430F-BF4D-5FDFBED9843C
wdt:P433
8
wdt:P478
101
p:P356
wds:Q73492524-88503A42-D3E7-4E30-BC76-54A6ACDA6961
wdtn:P356
n11:01.CIR.101.8.844
wdt:P356
10.1161/01.CIR.101.8.844